SCHEMBL4906301

SCHEMBL4906301

CCN(c1ccc(Oc2ccc(C(F)(F)F)cc2)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 2/20 0.51
LMNA P02545 1/20 0.47
MAPK1 P28482 1/20 0.46
HDAC3 O15379 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
NR1I2 O75469 1/20 0.45
RORA P35398 1/20 0.45
RORC P51449 1/20 0.45
NR1H2 P55055 1/20 0.45
NR1H3 Q13133 1/20 0.45
RORB Q92753 1/20 0.45
NR1H4 Q96RI1 1/20 0.45
PSEN1 P49768 1/20 0.45
PSEN2 P49810 1/20 0.45
APH1B Q8WW43 1/20 0.45
NCSTN Q92542 1/20 0.45
APH1A Q96BI3 1/20 0.45
PSENEN Q9NZ42 1/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4897635 0.91 HDAC8 (0.53) HDAC8LMNAMAPK1HDAC3HDAC11
SCHEMBL4906417 0.90 HDAC8 (0.52) HDAC8MAPK1HDAC3HDAC11HDAC6
SCHEMBL4904446 0.90 HCRTR2 (0.51) HDAC8LMNAMAPK1MCL1BCL2L1
SCHEMBL4897727 0.90 MMP2 (0.48) HDAC8LMNAMAPK1HDAC3HDAC11
SCHEMBL4894659 0.89 LMNA (0.53) HDAC8LMNAMAPK1HDAC3HDAC11
SCHEMBL4906264 0.89 LMNA (0.52) LMNAMAPK1MCL1BCL2L1ESR1
SCHEMBL4903991 0.89 LMNA (0.54) LMNANR1I2POLBMCL1BCL2L1
SCHEMBL4905211 0.88 LMNA (0.46) LMNANR1I2POLBMMP9MCL1
SCHEMBL4900633 0.87 LMNA (0.47) LMNAPOLBMCL1BCL2L1ESR1
SCHEMBL4895629 0.87 LMNA (0.49) LMNAMCL1BCL2L1ESR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD HDAC8 882/4885LMNA 319/4885MAPK1 3366/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD HDAC8 882/4885LMNA 319/4885MAPK1 3366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.